Patent details

Basic Information

Publication number:

EP2280719

PCT Application Number:

PCT/IB/2009/005750

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097348031

PCT Publication Number:

WO/2009/130600

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY

French Title of Invention:

UTILISATION THÉRAPEUTIQUE DE LA NEUROTOXINE BOTULINIQUE TYPE A DANS LE TRAITEMENT DE LA DOULEUR ASSOCIÉE À UNE NEUROPATHIE DIABÉTIQUE

German Title of Invention:

THERAPEUTISCHE VERWENDUNG VON BOTULINNEUROTOXIN TYP A ZUR BEHANDLUNG VON SCHMERZ IM ZUSAMMENHANG MIT DIABETISCHER NEUROPATHIE

SPC Number:

Dates

Filing date:

27/04/2009

Grant date:

07/09/2016

EP Publication Date:

07/09/2016

PCT Publication Date:

29/10/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/02/2011

EP B1 Publication Date:

07/09/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/04/2017

Expiration date:

27/04/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/04/2009

 

 

Name:

IPSEN PHARMA S.A.S.

Address:

65, Quai Georges Gorse, 92100 Boulogne-Billancourt, France (FR)

Inventor

1

Name:

CHABRIER DE LASSAUNIERE Pierre-Etienne

Address:

France (FR)

2

Name:

AUGUET Michel

Address:

France (FR)

3

Name:

FAVRE Christine

Address:

France (FR)

Priority

Priority Number:

0802321

Priority Date:

25/04/2008

Priority Country:

France (FR)

Classification

Main IPC Class:

A61K 38/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages